Why TRACE-AF?
Sudden/unexplained death or cardiac arrest occurred in ~1 in 5,000 patients after atrial fibrillation ablation in the MANIFEST-US registry. Studying these rare events will require learning from the patient, clinical and procedural characteristics of the rare patients who suffer these early unexplained deaths.
TRACE-AF will be a retrospective patient-level registry of all patients who suffered sudden/unexplained death, generalized coronary vasospasm or malignant arrhythmia early after catheter ablation for atrial fibrillation or related arrhythmias.
*MANIFEST-US. J Am Coll Cardiol. 2026; 87 (2): 172-193. PMID: 41389071